Arete Wealth Advisors »

Seres Therapeutics shares owned by Arete Wealth Advisors

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Arete Wealth Advisors from 13F filings

Historical chart of Arete Wealth Advisors investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Arete Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 25k 1.40
2023-09-30 $59k 25k 2.38
2023-06-30 $60k 13k 4.80

More positions owned by Arete Wealth Advisors

Abbvie (ABBV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Disney Walt Com Disney (DIS)
Abbott Laboratories (ABT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Fs Kkr Capital Corp (FSK)
Spdr Gold Trust Gold Shs (GLD)
Spdr Ser Tr Spdr Bloomberg (BIL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Ishares Tr Shrt Trs Bd Etf (SHV)

View all positions for Arete Wealth Advisors

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
Hudson Bay Capital Management
Bank of America Corporation
Millennium Management
Point72 Asset Management
Tang Capital Management
Handelsbanken Fonder AB
Charles Schwab Investment Management
Goldman Sachs Group
Advisor Group Holdings
Hrt Financial
T. Rowe Price Associates
Two Sigma Investments
Lion Point Capital

View all funds holding Seres Therapeutics